EFTA00287152.pdf

09/14(2016 10:25:44 AM FROM:LABCORPLCLSFO TO: LABCORP Page 1 of 9 r TO: LISA P Woodson Merre LabCorp Raritan L?Agin, Specamm Numb., Put klotIO 69 First Avenue Raritan. NJ 08869-1800 Control Mamba Atoms Number Account R • - Number - Rowe 252-436-4247-0 10416404914 31143092 I 68 Nbmc Um Nnw Anon Address Epstein Woodson Merrell PaimaimNme PuMwMADeNmx Jeffrey PadeaSP PricaMmac TwalVokame 44 E 67th St 212-750-9895 ar(Ymm) New York NY 10065 Dared Binh Sex Fladas 63/07/19 01/20/53 M Yes Patna Address Adair/boil lobnintioo 9 E 71ST ST NEW YORK NY 10021 UPIN: A62553 nmeusinreColkaed DneEmmed DmearAlimeRepited ProichaName NIM I Physician ID 09/08/16 08:23 09/08/16 09/13/16 15:06ET MERRELL , W Tout Ordeal NKR LipoProfile; Heavy Metals Profile II, Blood; CBC With Differential/Platelet; Comp. Metabolic Panel (14); IFE and PE, Serum; Urinalysis, Routine; Lipid Panel; Iron and TIBC; Testosterone,Free+Weakly Bound; Ca+PTH Intact; Vitamin B12 and Folate; Lyme Ab/Western Blot Reflex; Hemoglobin Alc; Thyroxine (T4) Free, Direct, S; DHEA-Sulfate; Cortisol; TSH; Rheumatoid Arthritis Factor; Prostate -Specific Ag, Serum; IGF-1; Vitamin D, 25-Hydroxy; Panel 083935; C-Reactive Protein, Cardiac; HCV Ab w/Rflx to Verification; ANA w/Reflex; Homocyst(e)ine, Plasma; Uric Acid, Serum; LDH; GGT; Magnesium, Serum; Zinc, Plasma or serum; Insulin; Ferritin, Serum; Test Code Change; Venipuncture TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAS tiHR LipoProfile LDL Particle Number 01 LDL-P 1562 High nmol/L <1000 01 Low < 1000 Moderate 1000 - 1299 Borderline -High 1300 - 1599 High 1600 - 2000 Very High > 2000 Lipids 01 LDL-C mg/dL 0 - 99 Triglyceride result indicated is too high for an accurate LDL cholesterol estimation. Optimal 100 Above optimal 100 - 129 Borderline 130 - 159 High 160 - 189 Very high 189 comment: 01 LDL-C is inaccurate if patient is non-fasting. HDL-C 27 Low mg/d1, >39 01 Triglycerides 476 High 0 - 149 01 Cholesterol, Total 214 High mg/dL 100 - 199 01 LDL and HDL Particles 01 HDL-P (Total) 22.5 Low umol/L >=30.5 01 Small LDL-P 1243 High nmol/L <=527 01 LDL Size 19.7 nm >20.5 01 Epstein, Jeffrey 252-436-4247-0 Scg N 8516 09/14/16 10:25 ET DUPLICATE FINAL REPORT Page 1 of 8 This dcaunent contains private and confidential health information protected by slat and federal law. 020C4-16iabcratay Corpontioo of America e Holdings If you have received this document in era please call 800-631-S2SO All Rights Relined DOCI Vet: 1.49 EFTA00287152 09/1412016 10:25:44 AM FROM: LABCORP LCLS Fe TO: LAsconi, Page 2 of 9 r TO: LISA P Woodson Merre i ll LabCorp Raritan 69 First Avenue Raritan, N1 0886 1800 : - Pagan Nam Specimmigumber Epstein, Jeffrey 252-436-4247-0 Ammar Number Peeled ID Control Number Date and Thee Collected DtieRepotted Sa Age(NANIM I/Annie& 31143092 10416404914 09/08/16 08:23 09/13/16 M 63/07/19 01/20/53 TESTS RESULT ELAG UNITS REITOUNICE INTERVAL LAB ** INTERPRETATIVE INFORMATION** PARTICLE CONCENTRATION AND SIZE <--Lower CVD Risk Higher CVD Risk--> LDL AND HDL PARTICLES Percentile in Reference Population HDL-P (total) High 75th 50th 25th Low >34.9 34.9 30.5 26.7 <26.7 Small LDL-P Low 25th 50th 75th High <117 117 527 839 >839 LDL Size <-Large (Pattern A)-> <-Small (Pattern B)-> 23.0 20.6 20.5 19.0 Comment: 01 Small LDL-P and LDL Size are associated with CVD risk, but not after LDL-P is taken into account. These assays were developed and their performance characteristics determined by LipoScience. These assays have not been cleared by the US Food and Drug Administration. The clinical utility of these laboratory values have not been fully established. Insulin Resistance Score 01 LP-IR Score 91 High <=45 01 INSULIN RESISTANCE MARKER <--Insulin Sensitive Insulin Resistant--> Percentile in Reference Population insulin Resistance Score LP-IR Score Low 25th 50th 75th High <27 27 45 63 >63 Comment: 01 LP-IR Score is inaccurate if patient is non-fasting. The LP-IR score is a laboratory developed index that has been associated with insulin resistance and diabetes risk and should be used as one component of a physician's clinical assessment. The LP-IR score listed above has not been cleared by the US Food and Drug Administration. Heavy Metals Profile II, Blood Lead, Blood None Detected ug/dL 0 - 19 01 Environmental Exposure: WHO Recommendation <20 Occupational Exposure: OSHA Lead Std 40 BEI 30 Detection Limit = 1 Epstein, Jeffrey 252-436-4247-0 SegOSM6 09/14/16 10:25 ET DUPLICATE FINAL REPORT Page 2 of 8 This document contains private and ccalidential health Information protected by In and federal law. 02024- I 6 Labceatory Corporation of America m Holdings If you have received ibis document in arar. please call 800-631-5250 AllRights Reserved DOCI Va: 149 EFTA00287153 09/14/2018 10:25:44 AM FROM:LABCORPLCUSF0 TO: LABCORP Page 3 of 9 r TO: LISA P Woodson Merre ll LabCorp Raritan L.A.Csarp 69 First Avenue Raritan. NJ 08869-1800 Patios Nave Phone: 800-631-5250 Spodmen Number Epstein, Jeffrey 252-436-4247-0 Amami Number PMea ID Coal Number Dale ad Time Colluded Dam Repotted Sec Age(YIM/D) Date of Beth 31143092 10416909919 09/08/16 08:23 09/13/16 M 63/07/19 01/20/53 TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAS Arsenic, Blood 4 ug/L 2 - 23 01 Detection Limit = 1 Mercury, Blood 2.2 ug/L 0.0 - 14.9 01 Environmental Exposure: <15.0 Occupational Exposure: BEI - Inorganic Mercury: 15.0 Detection Limit = 1.0 Cadmium, Blood None Detected ug/L 0.0 - 1.2 01 Environmental Exposure: Nonsmokers 0.3 - 1.2 Smokers 0.6 - 3.9 Occupational Exposure: OSHA Cadmium Std 5.0 BEI 5.0 Detection Limit = 0.5 CBC With Differential/Platelet WBC 5.8 x10E3/uL 3.4 10.8 02 RBC 4.95 x10E6/uL 4.14 5.80 02 Hemoglobin 14.1 g/dL 12.6 17.7 02 Hematocrit 41.9 8 37.5 51.0 02 MCV 85 fL 79 97 02 MCH 28.5 pg 26.6 33.0 02 MCHC 33.7 31.5 35.7 02 ROW 14.4 12.3 15.4 02 Platelets 232 xl0E3/uL 150 379 02 Neutrophils 51 8 02 Lymphs 32 8 02 Monocytes 9 8 02 Hos 7 8 02 Basos 1 8 02 Neutrophils (Absolute) 3.0 x10E3/uL 1.4 7.0 02 Lymphs (Absolute) 1.8 x10E3/uL 0.7 3.1 02 Monocytes(Absolute) 0.5 x10E3/uL 0.1 0.9 02 Eos (Absolute) 0.4 x10E3/uL 0.0 0.4 02 Baso (Absolute) 0.0 xl0E3/uL 0.0 0.2 02 Immature Granulocytes 0 8 02 Immature Grans (Abs) 0.0 x10E3/UL 0.0 0.1 02 - Comp. Metabolic Panel (14) Glucose, Serum 96 mg/dL 65 - 99 02 BUN 16 mg/c1L 8 - 27 02 Creatinine, Serum 0.94 mg/dL 0.76 - 1.27 02 eGFR If NonAfricn Am 86 mL/min/1.73 >59 eGFR If Africn Am 99 mL/min/1.73 >59 Epstein, Jeffrey 252-436-4247-0 SIN 48516 09/14/16 10:25 ET DUPLICATE FINAL REPORT Page 3 of 8 This dccwnent contains titivate and confidential health information protected by state and federal C2004-16 Laboratory Comondon of America m Holdings If you have received this domurient in error, please call 200-631-5230 All Rights Reserved DOCI Ver 1.49 EFTA00287154 09/141201610:25:444AM FROM:LABCORPLCLSFs TO: LABCORP Page 4 of 9 r TO: LISA P Woodson Merrell LibCorp Raritan Lalaggrap 69 First Avenue Raritan. NJ 08869-1800 pastoral= Phone: 800-631-5250 4ralatomiabo Epstein, Jeffrey 252-436-4247-0 Accoaot Number Nom ID Coon) Number Date awl Time Collected Doe Repotted Sex Ase(YrtND) Due of Bid, 31143092 10416404914 09/08/16 08:23 09/13/16 M 63/07/19 01/20/53 TESTS RESULT FLAG UNITS strounics INTERVAL BUN/Creatinine Ratio 17 10 22 Sodium, Serum 139 mmol/L 134 144 02 Potassium, Serum 4.4 mmol/L 3.5 5.2 02 Chloride, Serum 99 mmol/L 97 108 02 Carbon Dioxide, Total 22 mmol/L 18 29 02 Calcium, Serum 9.5 mg/dL 8.6 10.2 02 Protein, Total, Serum 6.7 g/dL 6.0 8.5 02 Albumin, Serum 4.3 g/dL 3.6 4.8 02 Globulin, Total 2.4 g/dL 1.5 4.5 A/G Ratio 1.8 1.1 2.5 Bilirubin, Total 0.8 mg/dL 0.0 1.2 02 Alkaline Phosphatase, S 63 IU/L 39 117 02 AST (SGOT) 30 IU/L 0 40 02 ALT (SGPT) 42 IU/L 0 44 02 IFE and PE, Serum Immunoglobulin G, Qn, Serum 1056 mg/dL 700 1600 02 Immunoglobulin A, Qn, Serum 224 mg/dL 61 437 02 Immunoglobulin M, Qn, Serum 42 mg/dL 20 172 02 Albumin 3.6 g/dL 2.9 4.4 02 Alpha-I-Globulin 0.2 g/dL 0.0 0.4 02 Alpha-2-Globulin 0.8 g/dL 0.4 1.0 02 Beta Globulin 1.0 g/dL 0.7 1.3 02 Gamma Globulin 1.0 g/dL 0.4 1.8 02 M-Spike Not Observed g/dL Not Observed 02 Globulin, Total 3.1 g/dL 2.2 - 3.9 A/G Ratio 1.2 0.7 - 1.7 Immunofixation Result, Serum 02 An apparent normal immunofixation pattern. Please note: 02 Protein electrophoresis scan will follow via computer, mail, or courier delivery. Urinalysis, Routine Urinalysis Gross Exam 02 specific Gravity 1.028 1.005 - 1.030 02 PH 5.5 5.0 - 7.5 02 Urine-Color Yellow Yellow 02 Appearance Clear Clear 02 WBC Esterase Negative Negative 02 Protein Negative Negative/Trace 02 Glucose Negative Negative 02 Ketones Negative Negative 02 Occult Blood Trace Abnormal Negative 02 Bilirubin Negative Negative 02 Urobilinogen,Semi-Qn 0.2 EU/dL 0.2 - 1.0 02 Nitrite, Urine Negative Negative 02 Epstein, Jeffrey 252-436-4247-0 Seq/18M6 09/14/16 10:25 ET DUPLICATE FINAL REPORT Page 4 of 8 This document contains private and confidential health information ',mind by stale and federal law. 02004-14GbaatayCorpomficmaAmmica011oldings If you have received this document in woe. please call 800-631-5250 AUFtightsResaved DOC1VerAA9 EFTA00287155 09/14/2016 10:25:44 AM FROM:LABCORPLCLSF8 LABCORP Page 5 of 9 r TO: LISA P Woodson Merre LabCorp Raritan LAkCosarP 69 First Avenue Raritan, NJ 08869-1800 ItadomName Phone: 800- - SeecitheaNtotther Epstein, Jeffrey 252-436-4247-0 Accaux ?Iamb« Pas ID Cocoa Nuatee Due end Thee Coleus Due Reported Sec Age(WAVD) Due of Bid. 31143092 10416404914 09/08/16 08:23 09/13/16 M 63/07/19 01/20/53 TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAS Microscopic Examination See below: 02 WBC 0-5 /hpf 0 - 5 02 BBC 0-2 /hpf 0 - 2 02 Epithelial Cells (non renal) None seen /hpf 0 - 10 02 Mucus Threads Present Not Estab. 02 Bacteria None seen None seen/Few 02 Lipid Panel Cholesterol, Total 214 High mg/dL 100 - 199 02 Triglycerides 470 High mg/dL 0 - 149 02 HDL Cholesterol 27 Low mg/dL >39 02 Comment 02 According to ATP-III Guidelines, HDL-C >59 mg/dL is considered a negative risk factor for CHD. VLDL Cholesterol Cal mg/dL 5 - 40 The calculation for the VLDL cholesterol is not valid when triglyceride level is >400 mg/dL. LDL Cholesterol Calc mg/dL 0 - 99 Triglyceride result indicated is too high for an accurate LDL cholesterol estimation. Iron and TIBC Iron Bind.Cap.(TIBC) 302 ug/dL 250 - 450 UIBC 219 ug/dL 111 - 343 02 Iron, Serum 83 ug/dL 38 - 169 02 Iron Saturation 27 15 - 55 Testosterone,Free+Weakly Bound Testosterone, Serum 153 Low ng/dL 348 - 1197 02 Comment: Adult male reference interval is based on a population of lean males up to 40 years old. Testost., 9 Free+Weakly Bound 31.6 9.0 - 46.0 01 Testost., F+W Bound 48.3 ng/dL 40.0 - 250.0 Ca+PTH Intact PTH, Intact 65 pg/mL 15 - 65 02 Intact PTH 02 Interpretation Intact PTH Calcium (pg/mL) (mg/dL) Normal 15 - 65 8.6 - 10.2 Primary Hyperparathyroidism >65 >10.2 Secondary Hyperparathyroidism >65 <10.2 Non-Parathyroid Hypercalcemia <65 >10.2 Hypoparathyroidism <15 < 8.6 Epstein, Jeffrey 252-436-4247-0 Seq08516 09/14/16 10325 ET DUPLICATE FINAL REPORT Page 5 of 8 This dectunentcontalns print and confidential health infonnadon protected by state and federal law. O2004-16 Labontay Corporation &America S Holdings If you have received this doctunent in MCC please call 800-631-5250 All Rights Reserved DOC1 Va: 1.49 EFTA00287156 09114/201610:25:44AM FROM:LABCORPLCISF6 TO: LABCORP Page 6 of 9 r TO: LISA P Woodson Merrell LabCorp Raritan Labgrap 69 First Avenue Phone: 800-631-5250 Raritan NJ 08869-1800 ibthaNum SpecharmNurber Epstein, Jeffrey 252-436-4247-0 Ana Sao Nem M Comet Nat Dee aornme Conected Date Mowed Sc Age(Y/M0) Date of Birth 31143092 10416404914 09/08/16 08:23 09/13/16 M 63/07/19 01/20/53 TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB Non-Parathyroid Hypocalcemia 15 - 65 < 8.6 Vitamin B12 and Folate Vitamin 812 945 pg/mL 211 - 946 02 Folate (Folic Acid), Serum 9.9 ng/m1, >3.0 02 Note: 02 A serum folate concentration of less than 3.1 ng/mL is considered to represent clinical deficiency. Lyme Ab/Western Blot Reflex Lyme IgG/IgM Ab <0.91 ISR 0.00 - 0.90 02 Negative <0.91 Equivocal 0.91 - 1.09 Positive >1.09 Lyme Disease Ab, Quant, IgM <0.80 index 0.00 - 0.79 02 Negative <0.80 Equivocal 0.80 - 1.19 Positive >1.19 IgM levels may peak at 3-6 weeks post infection, then gradually decline. Hemoglobin Aic Hemoglobin Aic 5.8 High 4.8 - 5.6 02 Please Note: 02 Pre-diabetes: 5.7 - 6.4 Diabetes: >6.4 Glycemic control for adults with diabetes: <7.0 Thyroxine (T4) Free, Direct, S T4,Pree(Direct) 1.13 ng/dL 0.82 - 1.77 02 DBEA-Sulfate 155.3 ug/dL 48.9 - 344.2 02 cortisol 14.1 ug/dL 02 Cortisol AM 6.2 - 19.4 Cortisol PH 2.3 - 11.9 TSB 1.800 uIU/mL 0.450 - 4.500 02 Rheumatoid Arthritis rector RA Latex Turbid. 5.8 IUML 0.0 - 13.9 02 Epstein, Jeffrey 252-436-4247-0 Seq I 8516 09/14/16 10:25 ET DUPLICATE FINAL REPORT Page 6 of 8 This document cornaim private and confidential health information protected by slate and federal law. 02001-16 Laboratory Corporation d America m Holdings If you have received this document m error, please call 800-631-5250 AU Rights Reserved DOC I Ver: 149 EFTA00287157 09114/201610:25:44AM FROM:LABCORPLCUSFe LABCORP Page 7 of 9 r TO: LISA P Woodson Me LQ,bQcarwp LabCorp Raritan 69 First Avenue Raritan NJ 08869-1800 Patient Name Phone: 800-631-5250 Spedmeo Number Epstein, Jeffrey 252-436-4247-0 Account Number Norm ID Coaxed Number Dam sod Time Collected Dae Rmoned St= Area/WD) Date of Bit) 31143092 10416404914 09/08/16 08:23 09/13/16 M 63/07/19 01/20/53 TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB Prostate-Specific Ag, Serum Prostate Specific Ag, Serum 0.6 ng/mL 0.0 - 4.0 02 Roche ECLIA methodology. According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA value 0.2 ng/mL or greater followed by a subsequent confirmatory PSA value 0.2 ng/mL or greater. Values obtained with different assay methods or kits cannot be used interchangeably. Results cannot be interpreted as absolute evidence of the presence or absence of malignant disease. IGF-1 Insulin-Like Growth Factor I 151 ng/ra. 49 - 188 01 Vitamin D, 25-Hydroxy 34.0 ng/mL 30.0 - 100.0 02 Vitamin D deficiency has been defined by the Institute of Medicine and an Endocrine Society practice guideline as a level of serum 25-OH vitamin D less than 20 ng/mL (1,2). The Endocrine Society went on to further define vitamin D insufficiency as a level between 21 and 29 ng/mL (2). 1. IOM (Institute of Medicine). 2010. Dietary reference intakes for calcium and D. Washington DC: The National Academies Press. 2. Holick MF, Hinkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine society clinical practice guideline. JCEM. 2011 Jul; 96(7):1911-30. Panel 083935 HIV Screen 4th Generation wRfx Non Reactive Non Reactive 02 C-Reactive Protein, Cardiac 3.39 High mg/L 0.00 - 3.00 02 Relative Risk for Future Cardiovascular Event LOW <1.00 Average 1.00 - 3.00 High >3.00 HCV Ab w/Rflx to Verification HCV Ab <0.1 s/co ratio 0.0 - 0.9 02 Comment: 02 Non reactive HCV antibody screen is consistent with no HCV infection, unless recent infection is suspected or other evidence exists to indicate HCV infection. Epstein, Jeffrey 252-436-4247-0 Seq #8516 09/14/16 10:25 ET DUPLICATE FINAL REPORT Page 7 of 8 This document contains private and confidential health information protected by state and federal law. 02004-16 Laboratory Corporation of America 0 Holdings lf you have received this document in error, please call 800-631-5250 All Rights Reserved DOCI Vet 1.49 EFTA00287158 09/14/2016 10:25:44 AM FROM: LABCORP LCLS F6 T LABCORP Pegs 8 of 9 r TO: LISA P Woodson M LabCorp Raritan L&Qcsp 69 First Avenue Raritan NJ 08869-1800 DeiccoName Phes6:800-631-5250 Specimen Hunter Epstein, Jeffrey 252-436-4247-0 Mooing Hinter Poirot M Oman) Nuts Dow and Thus °Awed Das Reporeed Sot Ase0(440 Date of Birds 31143092 10416404914 09/08/16 08:23 09/13/16 M 63/07/19 01/20/53 TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB ANA w/Reflex ANA Direct Negative Negative 02 Romocyst(e)ine, Plasma 16.0 High umol/L 0.0 - 15.0 02 Uric Acid,